BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 11230706)

  • 1. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas.
    Kumaki F; Kawai T; Hiroi S; Shinomiya N; Ozeki Y; Ferrans VJ; Torikata C
    Hum Pathol; 2001 Feb; 32(2):188-95. PubMed ID: 11230706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer.
    Saito K; Yagihashi A; Nasu S; Izawa Y; Nakamura M; Kobayashi D; Tsuji N; Watanabe N
    Jpn J Cancer Res; 2002 Mar; 93(3):253-8. PubMed ID: 11927006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase.
    Kyo S; Masutomi K; Maida Y; Kanaya T; Yatabe N; Nakamura M; Tanaka M; Takarada M; Sugawara I; Murakami S; Taira T; Inoue M
    Am J Pathol; 2003 Sep; 163(3):859-67. PubMed ID: 12937127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma.
    Izumi H; Hara T; Oga A; Matsuda K; Sato Y; Naito K; Sasaki K
    Neoplasia; 2002; 4(2):103-11. PubMed ID: 11896565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy.
    Rotem O; Zer A; Yosef L; Beery E; Goldvaser H; Gutkin A; Levin R; Dudnik E; Berger T; Feinmesser M; Levy-Barda A; Lahav M; Raanani P; Uziel O
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371825
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer.
    Oršolić N; Jazvinšćak Jembrek M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.
    Matsuda Y; Yamashita T; Ye J; Yasukawa M; Yamakawa K; Mukai Y; Machitani M; Daigo Y; Miyagi Y; Yokose T; Oshima T; Ito H; Morinaga S; Kishida T; Minamoto T; Yamada S; Takei J; Kaneko MK; Kojima M; Kaneko S; Masaki T; Hirata M; Haba R; Kontani K; Kanaji N; Miyatake N; Okano K; Kato Y; Masutomi K
    J Pathol; 2022 Jun; 257(2):172-185. PubMed ID: 35094384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Suppressor LKB1 inhibits both the mRNA Expression and the Amplification of hTERC by the Phosphorylation of YAP in Lung Cancer Cells.
    He L; Wu MZ; Wang XB; Qiu XS; Wang EH; Wu GP
    J Cancer; 2019; 10(16):3632-3638. PubMed ID: 31333780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase Inhibitors from Natural Products and Their Anticancer Potential.
    Ganesan K; Xu B
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase Inhibitory Effects of Red Pigment Rubropunctatin and Statin Monacolin L Isolated from Red Yeast Rice.
    Xu B; Wang Q; Sung C
    Genes (Basel); 2017 Apr; 8(5):. PubMed ID: 28445391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines.
    Menez-Jamet J; Gallou C; Rougeot A; Kosmatopoulos K
    Ann Transl Med; 2016 Jul; 4(14):266. PubMed ID: 27563653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity in non-small cell lung cancer.
    Dobija-Kubica K; Zalewska-Ziob M; Bruliński K; Rogoziński P; Wiczkowski A; Gawrychowska A; Gawrychowski J
    Kardiochir Torakochirurgia Pol; 2016 Mar; 13(1):15-20. PubMed ID: 27212973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2D3 is a positive prognostic factor and is negatively correlated with hTERT expression in esophageal cancer.
    Guan GG; Wang WB; Lei BX; Wang QL; Wu L; Fu ZM; Zhou FX; Zhou YF
    Oncol Lett; 2015 Apr; 9(4):1567-1574. PubMed ID: 25789002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activation of hTERT-specific T cell responses in lung cancer patients following chemotherapy.
    Gahn B; Staudinger M; Woester K; Wellnitz D; Boettcher S; Gramatzki M; Kneba M
    J Thorac Dis; 2013 Jun; 5(3):240-50. PubMed ID: 23825754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non-small cell lung cancer: results from Cancer and Leukemia Group B 159902.
    Boylan AM; Wang XF; Ko R; Watson PM; Gu L; Harpole D; Bueno R; Kelly R; Kohman L; Kratzke R
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):206-11. PubMed ID: 23026566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Leptin, hTERT Gene Expression, and Anthropometric Measures in Obese and Non-Obese Women with Breast Cancer.
    Rahmati-Yamchi M; Zarghami N; Rahbani M; Montazeri A
    Breast Cancer (Auckl); 2011 Mar; 5():27-35. PubMed ID: 21494399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase detection in the diagnosis and prognosis of cancer.
    Hiyama E; Hiyama K
    Cytotechnology; 2004 Jun; 45(1-2):61-74. PubMed ID: 19003244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbaric oxygen therapy for malignancy: a review.
    Daruwalla J; Christophi C
    World J Surg; 2006 Dec; 30(12):2112-31. PubMed ID: 17102915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.
    Zhu CQ; Shih W; Ling CH; Tsao MS
    J Clin Pathol; 2006 Aug; 59(8):790-800. PubMed ID: 16873561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
    Zhu CQ; Cutz JC; Liu N; Lau D; Shepherd FA; Squire JA; Tsao MS
    Br J Cancer; 2006 May; 94(10):1452-9. PubMed ID: 16641908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.